GlyCosmos Glycolipids
Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
| Database | Last Updated |
|---|---|
| ChEBI | February 3, 2022 |
| KEGG | February 3, 2022 |
| LIPID MAPS Structure Database | February 3, 2022 |
| LipidBank | February 3, 2022 |
| PubChem | February 3, 2022 |
| Main Class | Sub Class | LM ID | Common Name | LipidBank ID | KEGG ID | PubChem CID | ChEBI ID | Exact Mass ▲ | Formula |
|---|---|---|---|---|---|---|---|---|---|
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
GlcCer(d18:2(4E,8Z)/16:0)
|
697.549269
|
C40H75NO8
|
|||||
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
GlcCer(d17:2(4E,8E)(9Me)/16:0)
|
697.549269
|
C40H75NO8
|
|||||
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
GlcCer(d18:2/16:0)
|
697.549269
|
C40H75NO8
|
|||||
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
GlcCer(d14:2(4E,6E)/20:0)
|
697.549269
|
C40H75NO8
|
|||||
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
GlcCer(d16:2(4E,6E)/18:0)
|
697.549269
|
C40H75NO8
|
|||||
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
GalCer(d18:2/16:0)
|
697.549269
|
C40H75NO8
|
|||||
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
GlcCer(d18:1/16:0)
|
699.564919
|
C40H77NO8
|
|||||
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
GlcCer(d14:1/20:0)
|
699.564919
|
C40H77NO8
|
|||||
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
GlcCer(d16:1/18:0)
|
699.564919
|
C40H77NO8
|
|||||
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
GalCer(d18:1/16:0)
|
699.564919
|
C40H77NO8
|
Displaying entries 21 - 30 of 3908 in total
To see the latest features, please visit our beta site.
International Collaboration
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Acknowledgements
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
